DK3294288T3 - Inhibitorer af replikation af humant papillomavirus - Google Patents
Inhibitorer af replikation af humant papillomavirus Download PDFInfo
- Publication number
- DK3294288T3 DK3294288T3 DK16722201.7T DK16722201T DK3294288T3 DK 3294288 T3 DK3294288 T3 DK 3294288T3 DK 16722201 T DK16722201 T DK 16722201T DK 3294288 T3 DK3294288 T3 DK 3294288T3
- Authority
- DK
- Denmark
- Prior art keywords
- inhibitors
- human papillomavirus
- papillomavirus replication
- replication
- human
- Prior art date
Links
- 241000701806 Human papillomavirus Species 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 230000010076 replication Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562159572P | 2015-05-11 | 2015-05-11 | |
| PCT/EP2016/060584 WO2016180892A1 (en) | 2015-05-11 | 2016-05-11 | Human papilloma virus replication inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3294288T3 true DK3294288T3 (da) | 2022-01-03 |
Family
ID=57247862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16722201.7T DK3294288T3 (da) | 2015-05-11 | 2016-05-11 | Inhibitorer af replikation af humant papillomavirus |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US10543218B2 (da) |
| EP (1) | EP3294288B1 (da) |
| CA (1) | CA2985682A1 (da) |
| DK (1) | DK3294288T3 (da) |
| ES (1) | ES2901978T3 (da) |
| WO (1) | WO2016180892A1 (da) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20041248A1 (it) | 2004-06-22 | 2004-09-22 | Need Pharma S R L | Impiego di composti eterociclici azotati e relative composizioni come microbicidi |
| WO2008062662A1 (fr) | 2006-11-21 | 2008-05-29 | Konica Minolta Opto, Inc. | Procédé pour produire un substrat en verre pour un support d'enregistrement d'informations, substrat en verre pour un support d'enregistrement d'informations et support d'enregistrement d'informations |
| WO2008063662A2 (en) * | 2006-11-21 | 2008-05-29 | Black Lion Pharmaceuticals | Gold (iii) chloride compositions for cancer |
| US8940740B2 (en) * | 2010-10-28 | 2015-01-27 | Southern Research Institute | Small molecule inhibitors of bacterial motility and a high throughput screening assay for their identification |
| EP3280816A1 (en) | 2015-04-09 | 2018-02-14 | Icosagen Cell Factory OÜ | Assay system to identify hpv replication inhibitors in ht-screen |
-
2016
- 2016-05-11 EP EP16722201.7A patent/EP3294288B1/en active Active
- 2016-05-11 CA CA2985682A patent/CA2985682A1/en active Pending
- 2016-05-11 ES ES16722201T patent/ES2901978T3/es active Active
- 2016-05-11 US US15/573,362 patent/US10543218B2/en active Active
- 2016-05-11 WO PCT/EP2016/060584 patent/WO2016180892A1/en active Application Filing
- 2016-05-11 DK DK16722201.7T patent/DK3294288T3/da active
-
2019
- 2019-09-12 US US16/568,310 patent/US11000529B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2985682A1 (en) | 2016-11-17 |
| ES2901978T3 (es) | 2022-03-24 |
| US11000529B2 (en) | 2021-05-11 |
| US20200046730A1 (en) | 2020-02-13 |
| US10543218B2 (en) | 2020-01-28 |
| EP3294288B1 (en) | 2021-09-29 |
| US20180133228A1 (en) | 2018-05-17 |
| WO2016180892A1 (en) | 2016-11-17 |
| EP3294288A1 (en) | 2018-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3102576T3 (da) | Dihydropyrrolopyridininhibitorer af ror-gamma | |
| DK3160956T3 (da) | Inhibitorer af lysin-specifik demethylase-1 | |
| PT3286166T (pt) | Inibidores de replicação do vírus da imunodeficiência humana | |
| DK3851537T5 (da) | Behandling af hyperbilirubinæmi | |
| DK3137169T3 (da) | Hæmmere af lysin-specifik demethylase-1 | |
| DK3511319T3 (da) | Hæmmere af lysinspecifik demethylase-1 | |
| DK3202086T3 (da) | Tilstandsreplikation af virtuelle netværksfunktionsinstanser | |
| BR112017002231A2 (pt) | novas formulações de um inibidor de tirosina cinase de bruton | |
| DK3160470T3 (da) | Analoger af pridopidin, fremstilling og anvendelse heraf | |
| DK3116533T3 (da) | Deletion af dystrophingenexon under anvendelse af genmanipulerede nukleaser | |
| IL245213A0 (en) | Inhibitors of human immunodeficiency virus replication | |
| DK3244948T3 (da) | Bestemmelse af medikamentdosis | |
| DK3068776T3 (da) | Inhibitorer af replikation af influenzavira | |
| DK3144001T3 (da) | Sammensætninger af selenoorganiske forbindelser og fremgangsmåder til anvendelse deraf | |
| DK3227310T3 (da) | Heterobifunktionelle inhibitorer af e-selektiner og cxcr4-kemokin-receptorer | |
| DK3240612T3 (da) | Fremgangsmåder til behandling af nethindesygdomme | |
| DK3204398T3 (da) | Fremgangsmåder til fraseparering af gemcitabin-phosphat diastereoisomerer | |
| DK3307267T3 (da) | Behandling af multipel sklerose | |
| DK3164394T3 (da) | Gls1-inhibitorer til behandling af sygdomme | |
| DK3283210T3 (da) | Fremgangsmåde | |
| DK3166628T3 (da) | Terapeutisk anvendelse af knoglemorfogenetiske proteiner | |
| DK3094322T3 (da) | Administration af tasimelteon i fastende tilstand | |
| DK3390422T3 (da) | Krystalformer af lnt | |
| DK3237621T3 (da) | Varianter af human alpha-galactosidase | |
| DK3204352T3 (da) | Hæmmere af lysin-gingipain |